[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
[ Tue, Apr 02nd 2024 ]: WOPRAI
Joshua Spector Maintained (CC) at Hold with Increased Target to $28 on, Apr 2nd, 2024
- 🞛 This publication is a summary or evaluation of another publication
Joshua Spector of UBS, Maintained "The Chemours Company" (CC) at Hold with Increased Target from $21 to $28 on, Apr 2nd, 2024.
Joshua has made no other calls on CC in the last 4 months.
There is 1 other peer that has a rating on CC. Out of the 1 peers that are also analyzing CC, 0 agree with Joshua's Rating of Hold.
This is the rating of the analyst that currently disagrees with Joshua
- John McNulty of "BMO Capital" Downgraded from Buy to Sell and Decreased Target to $19 on, Friday, March 1st, 2024